Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for China Resources Medical Holdings Co's Intrinsic Value: Projected FCF or its related term are showing as below:
CMHDF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.21 Med: 0.54 Max: 1.6
Current: 0.21
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of China Resources Medical Holdings Co was 1.60. The lowest was 0.21. And the median was 0.54.
CMHDF's Price-to-Projected-FCF is ranked better than 97.41% of 347
companies
in the Healthcare Providers & Services industry
Industry Median: 1.04
vs CMHDF: 0.21
China Resources Medical Holdings Co (OTCPK:CMHDF) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
China Resources Medical Holdings Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.58
/
1.5646774387456
=
0.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Intrinsic Value: Projected FCF Related Terms
China Resources Medical Holdings Co Intrinsic Value: Projected FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Intrinsic Value: Projected FCF Chart
CMHDF vs HCA, THC, EHC: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's Price-to-Projected-FCF falls into.
China Resources Medical Holdings Co Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $2.82 mean?
China Resources Medical Holdings Co (CMHDF) has a Intrinsic Value: Projected FCF of $2.82 as of Sep. 17, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on China Resources Medical Holdings Co and its competitors. According to the industry distribution chart, China Resources Medical Holdings Co ranks #9 out of 347 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is China Resources Medical Holdings Co's Intrinsic Value: Projected FCF too high?
China Resources Medical Holdings Co's current Intrinsic Value: Projected FCF is $2.82. The Healthcare Providers & Services industry median Intrinsic Value: Projected FCF is 1.04. China Resources Medical Holdings Co's value of $2.82 is 171.2% above this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #9 out of 347 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Medical Holdings Co has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #9 out of 347 companies for Intrinsic Value: Projected FCF. This places China Resources Medical Holdings Co in the top 3% of its industry — outperforming the majority of peers. The industry median Intrinsic Value: Projected FCF is 1.04. China Resources Medical Holdings Co's value of $2.82 is 171.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.04, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Intrinsic Value: Projected FCF of $2.82 is 171.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Intrinsic Value: Projected FCF is $2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Intrinsic Value: Projected FCF of $2.82. The stock's GF Value™ is $0.95, compared to a current price of $0.58 — trading 38.9% below its estimated fair value. The current Intrinsic Value: Projected FCF is $2.82 and 171.2% above the Healthcare Providers & Services industry median of 1.04. China Resources Medical Holdings Co's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Intrinsic Value: Projected FCF is $2.82 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 38.9% below its estimated GF Value™ of $0.95.
Key valuation signals for CMHDF:
Intrinsic Value: Projected FCF: $2.82
GF Value™: $0.95 vs. price of $0.58 (38.9% below fair value)
Industry Position: 171.2% above the Healthcare Providers & Services median (#9 of 347)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
93GF Score
Get the complete analysis for CMHDF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
